| Group/Lipid Parameter |
Control Month |
Treatment (Month 6) |
|
| LNG 31 |
|
|
Total cholesterol |
198.4 ± 5.7 |
179.8 ± 6.7 |
| LDL cholesterol |
127.4 ± 5.7 |
117.3 ± 5.9 |
| HDL cholesterol |
51.7 ± 2.4 |
45.0 ± 2.1 |
| HDL2 |
8.6 ± 1.0 |
7.7 ± 0.8 |
| HDL3 |
43.1 ± 1.6 |
37.3 ± 1.7 |
| Apo-Al |
141.4 ± 3.6 |
125.8 ± 4.9 |
| Triglycerides |
94.3 ± 10.5 |
85.3 ± 7.9 |
| LNG 62 |
|
|
| Total cholesterol |
176.3 ± 6.8 |
161.5 ± 8.0 |
| LDL cholesterol |
110.7 ± 6.3 |
101.8 ± 6.4 |
| HDL cholesterol |
45.6 ± 2.7 |
37.7 ± 1.8 |
| HDL2 |
7.1 ± 1.0 |
5.1 ± 0.4 |
| HDL3 |
38.5 ± 1.9 |
32.95 ± 1.5 |
| Apo-Al |
129.4 ± 4.5 |
110.4 ± 3.7 |
| Triglycerides |
98.5 ± 14.6 |
102.7 ± 12.8 |
|
| *LNG indicates levonorgestrel; LDL, low-density lipoprotein; and HDL,
high-density lipoprotein |
| Conversion factor to SI units for total, LDL, HDL cholesterol = 0.259
and for triglycerides = 0.0113 |
| P < .05 compared with T+LNG 62 |
| P < .05 compared with baseline |
|
